The authors wish to make the following corrections to this paper [1]:
In the original article, there was a mistake in Figure 1 as published. The IHC of “WNT subgroup + GAB1” was incorrectly the same IHC as in “non-SHH/WNT subgroup+YAP1.” We probably made a mistake while assembling the picture. The corrected Figure 1 appears below. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.
Figure 1.
Classification of medulloblastoma by immunohistochemical staining. Cases were classified into WNT subgroup (nuclear β-catenin, positive; GAB1, negative; and YAP1, positive), SHH subgroup (nuclear β-catenin, negative; GAB1, positive; YAP1, positive; and filamin A, positive), and non-SHH/WNT subgroup (nuclear β-catenin, negative; YAP1, negative; and filamin A, negative). Representative pictures (40×) of each subgroup are shown.
Reference
- Visani, M.; Marucci, G.; de Biase, D.; Giangaspero, F.; Buttarelli, F.R.; Brandes, A.A.; Franceschi, E.; Acquaviva, G.; Ciarrocchi, A.; Rhoden, K.J.; et al. miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children. Diagnostics 2020, 10, 265. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).